NCT00128271View on ClinicalTrials.gov

Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

August 31, 2006

Conditions
Hepatitis C
Interventions
DRUG

Bavituximab

Trial Locations (1)

34205

Bach & Godofsky, MD, PA, Bradenton

Sponsors
All Listed Sponsors
lead

Peregrine Pharmaceuticals

INDUSTRY